Yashpal Singh Rawat: Fortis Memorial Research Institute Made Its Positive Mark at ASH
Yashpal Singh Rawat, Vice President and Facility Director at Fortis Healthcare, shared on LinkedIn:
”Fortis Memorial Research Institute made its positive mark at ASH in USA !
It is a moment of immense pride for all of us at Fortis Memorial Research Institute, Gurugram to witness our institution represented on the global stage at the American Society of Hematology (ASH) 2025 Annual Meeting in Orlando, USA- the most prestigious and influential conference in the field of hematology.
Dr. Rahul Bhargava’s podium oral presentation on “Dissecting India’s Molecular Hematology Landscape: A 1000-patient genomic study” marks not just a scientific achievement but a defining milestone for FMRI.
Taking FMRI’s research from Gurugram to an international platform of this calibre reflects the depth, rigor, and innovation of the work being done here.
This recognition is a testament to the dedication of the entire molecular hematology team-the scientists, clinicians, technologists, and collaborators whose relentless efforts made this study possible.
Your commitment to advancing genomic medicine in India has now been acknowledged at the highest level in global hematology.
Congratulations to Dr. Rahul Bhargava for representing FMRI with excellence, and kudos to every team member who contributed to this landmark achievement.
This is just the beginning, and we look forward to many more such accomplishments that continue to position FMRI as a leader in cutting-edge hematology research.
Proud moment for FMRI.
Proud moment for Fortis Family.”
All from ASH25 featured in Hemostasis Today.
-
Oct 13, 2026, 02:01Nour Al-Mozain: Is It Really Anti-D? – Unraveling Auto-Anti-LW in the Transfusion Laboratory
-
Oct 13, 2026, 01:51Berenice Villegas: The Role of Morphologic Evaluation in Body Fluid Differential Analysis
-
Oct 13, 2026, 01:44Debadrita Ray: Evaluating vWF and VITRO Score for Detecting CSPH in cACLD Patients
-
Oct 13, 2026, 01:34Nagesh Ramesh: Donating Blood for International Plasma Awareness Week
-
Oct 12, 2026, 21:51Sam Botchey: Orthobiologics Are Advancing but the Evidence Must Keep Pace
-
Oct 12, 2026, 21:50Serum Vitamin D, Platelet Function, and Bleeding in Primary ITP – Platelets Journal
-
Oct 12, 2026, 21:30Nika Samadzadeh Tabrizi: Looking Forward to the PACeS Trial on Anticoagulation for POAF
-
Oct 12, 2026, 21:28Michael Megaly: Does Coronary Ectasia Affect Outcomes in Acute Coronary Syndromes?
-
Oct 12, 2026, 21:25Vitor Borin P. de Souza: Think Twice Before Anticoagulating an Isolated Subsegmental PE